Cann Group Share Price Up on Licence (ASX:CAN)

By ,

At time of writing, the share price of Cann Group Limited [ASX:CAN] is down 1.36%, trading at $2.17.

The Cann Group share price has fluctuated throughout the last 12 months with a bottom occurring in March followed by a sharp spike on the announcement of an offtake agreement:

ASX CAN Cann Group Price Chart


Cann Group got manufacturing licenses for their facilities in Melbourne today, but their main focus will be on the Canadian market. We look at their valuation.

Free Download: Find out which four unique ASX-listed cannabis companies we are watching in this free report.

Cann Group share price indicates manufacturing licence not a surprise

With limited news coming out of the company in the last month, you could hazard a guess that some investors may have seen the manufacturing license news coming.

Today’s trading started with shares going for as much as $2.34 before the share price settled in the $2.15–$2.20 range.

The company announced that the Office of Drug Control (ODC) had approved licenses for the company’s existing Northern and Southern facilities which allows the company to manufacture, pack, store transport and dispose of medicinal cannabis.

The company notes that, ‘Appropriate permits will be required in relation to the undertaking of specific activities under the licences.

And that, ‘Cann Group now holds all cultivation, production and manufacture licences under the Narcotics Drugs Act, along with import and export licences under the Customs Act.

The next major step is getting their Mildura cultivation facility up and running.

For now, Cann Group CEO Peter Crock says that IDT Australia Limited [ASX:IDT] will play an immediate role: ‘IDT, which has GMP approved facilities, offers us immediate access to proven expertise in pharmaceutical manufacturing while we continue to develop our own capabilities.

But is the Cann Group share price cheap?

A lot depends on your investment horizon and willingness to wait out uncertainty in an evolving regulatory environment.

Cann Group has big things planned, with the 34,000 square metre Mildura operation to cost an estimated $130 million to construct and an expected production capacity of 50,000 kgs of dry flower.

But once up and running, the large majority of this flower will likely not be for the Australian market — which is still in its infancy.

Instead, it will be for export to Aurora Cannabis Inc. — a Canadian cannabis company which owns 22.9% of Cann.

Aurora has an offtake agreement in place for Cann’s flower which cover Cann’s full production capacity excluding domestic needs through until 2024.

Cann expects that once they are fully operational, they will generate annual revenue of $160–$200 million.

The Mildura facility is expected to be fully commissioned in the third quarter of CY2020, so investors might have to wait a while before serious revenue is generated by Cann Group.

If they actually pull in $160–$200 million a year their current market-cap of $311 million could be seen as a low valuation.

As of the end of March, they had $62.9 million, so a capital raise may be needed at some point if the $130 million Mildura is to be completed.

While all of this is a fair way down the track, if new shares are issued at discount, this could be an opportune moment to think about your position in Cann.

If you are interested in ASX-listed cannabis plays like Cann Group, our free report, which covers our ‘Top Four Pot Stocks’ is a great place to either begin your reading, or expand your knowledge. It can be downloaded here.


Lachlann Tierney,

For Money Morning





About Lachlann Tierney

Lachlann Tierney is an Analyst for Money Morning and has been investing for nearly a decade. With a Masters of Science from the London School of Economics, he brings a sound understanding of global markets to his writing. Lachlann is interested in emerging technologies, energy solutions and helping people invest…

Cann Group Shares Down as It Releases Quarterly Update (ASX:CAN)

Languishing pot stock Cann Group Ltd [ASX:CAN] is being punished by investors today. The CAN share price is down 14.47% at time of writing, falling substantially as management revealed a decent quarterly result and plans for a fresh capital raise.

Cann Group Share Price Rises on Positive News 12.86% (ASX:CAN)

At the time of writing shares of Cann Group Ltd (ASX:CAN) trade at 39.5 cents, up 12.86%. The CAN share price was up on news the medical cannabis company gained approval for new banking debt facilities…

Elixinol Share Price Down: Two Thoughts on its Future

After going to almost $6 a share, it is going for almost a tenth of this price today. We look at what has happened to the Elixinol share price and the company’s restructure.

Why ASX Cannabis Stocks are Down — Should You Invest?

It’s been a tough year for ASX cannabis stocks with many companies shedding value over a 12-month window. Only Althea has emerged from the last year with a gain to show for it. It’s worth taking a look at the ETFMG Alternative Harvest ETF chart to see what’s happening to cannabis stocks globally….

CAN Share Price in the Red: Should You Avoid Large Cannabis Companies?

Indeed, the cannabis craze does appear to be dying down in recent months. But this doesn’t mean the sector no longer has potential. Perhaps it just means bigger isn’t always better when it comes to pot stocks.

Cann Group Share Price Up on New Facility & Offtake Agreement

The latest news out of the company is that it has reached an agreement to purchase a site in the Mildura region as well as the announcement of a five-year offtake agreement with Aurora Cannabis.